MAGNOLIA, Texas, April 29,
2024 /PRNewswire/ -- Stratus® Medical, a company
focused on improving clinical outcomes for chronic pain patients by
advancing radiofrequency (RF) technology for the treatment of pain,
announced today the expansion of patent protection in Europe for its NIMBUS® Electrosurgical RF
Multitined Expandable Electrode ("NIMBUS") with the issuance of
European Patent Numbers EP3556308 and EP3750501. Both patents have
been validated in the United
Kingdom, Ireland, and
Spain and as Unitary Patents
covering France, Germany, Italy, and all other countries under the
Unitary Patent system. The Company's global patent portfolio for
NIMBUS now includes 37 grants, of which 16 are national validations
and Unitary Patents stemming from four separate European
applications and five are U.S. patents, and further includes five
pending applications and registrations.
Additionally, the Company has registered a Community design with
the European Union Intellectual Property Office for its forthcoming
platform technology, which is in late-stage development. This
platform technology has not yet been submitted to or cleared by the
FDA and has not yet received its CE Mark. Six U.S. and PCT
applications are pending for the Company's forthcoming
technologies.
Bret Boudousquie, Stratus
Medical's CEO, stated, "Stratus Medical has made significant
investment in product development projects to advance RF technology
for the treatment of pain. We understand the importance of
protecting both our valuable RF ablation technologies that are
rapidly gaining market share and our future technologies that are
in development. These recently issued European patents are
particularly important as we continue to gain momentum with NIMBUS
in Europe."
About Stratus® Medical – Stratus Medical's mission is to improve
clinical outcomes for chronic pain patients by advancing RF
technology. NIMBUS, in combination with a radiofrequency (RF)
generator and thermocouple probe, is intended for use in RF heat
lesion procedures for relief of pain. NIMBUS, which is FDA cleared
and CE marked, is easy to implement into existing workflow, has
demonstrated reduced procedure time, has been validated to provide
durable and sustained pain relief in independent clinical studies,
and delivers substantial savings for our customers. Stratus Medical
continues to invest in developing technologies that are aligned
with our mission. We are headquartered in Magnolia, Texas.
Media Contact
Cody Jorgensen
Director, Marketing
Stratus Medical
346-703-0642
cody@stratusmedical.com
https://stratusmedical.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/stratus-medical-announces-continued-expansion-of-its-intellectual-property-coverage-in-europe-with-additions-to-its-global-patent-portfolio-for-the-nimbus-electrosurgical-rf-multitined-expandable-electrode-and-registration-of-a--302130417.html
SOURCE Stratus Medical